Sukhatme Mayukh

CIK 00017500501 companyLONDON

SEC Profile

Transactions

Companies

Filings

CIK

0001750050

Recent Transactions

50 trades

Tax Payment
Roivant Sciences Ltd.$ROIV
Common Shares
2026-03-31$27.70/sh−187,512→ 18,677,617 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Capped Value Appreciation Rights
2026-03-30$11.50/sh−1,306,889→ 0 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Common Shares
2026-03-30+58,391→ 18,894,938 total
Tax Payment
Roivant Sciences Ltd.$ROIV
Common Shares
2026-03-30$26.41/sh−29,809→ 18,865,129 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Stock Option (Right to Buy)
2026-02-09−651,558→ 0 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Common Shares
2026-02-09$12.68/sh+651,558→ 19,488,105 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2026-02-09$26.47/sh−339,441→ 19,148,664 total
Other
Roivant Sciences Ltd.$ROIV
Common Shares
2026-02-09$26.47/sh−312,117→ 18,836,547 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Common Shares
2025-12-31$12.68/sh+2,449,877→ 21,286,424 total
Other
Roivant Sciences Ltd.$ROIV
Common Shares
2025-12-31$21.71/sh−1,430,882→ 18,836,547 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2025-12-31$21.71/sh−1,018,995→ 20,267,429 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Stock Option (Right to Buy)
2025-12-31−2,449,877→ 95,718 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Common Shares
2025-12-29$12.68/sh+748,358→ 19,584,905 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Stock Option (Right to Buy)
2025-12-29−748,358→ 555,840 total
Other
Roivant Sciences Ltd.$ROIV
Common Shares
2025-12-29$21.74/sh−436,485→ 18,836,547 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2025-12-29$21.74/sh−311,873→ 19,273,032 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2025-12-17$23.09/sh−26,831→ 18,869,229 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Common Shares
2025-12-17−59,513→ 1,304,198 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Common Shares
2025-12-17$12.68/sh+59,513→ 18,896,060 total
Other
Roivant Sciences Ltd.$ROIV
Common Shares
2025-12-17$23.09/sh−32,682→ 18,836,547 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Stock Option (Right to Buy)
2024-12-26−689,495→ 15,224,363 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2024-12-26$12.01/sh−689,495→ 18,836,547 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Common Shares
2024-12-26$3.85/sh+689,495→ 19,526,042 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2024-12-24$12.00/sh−185,946→ 18,836,547 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Stock Option (Right to Buy)
2024-12-24−185,946→ 15,913,858 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Common Shares
2024-12-24$3.85/sh+185,946→ 19,022,493 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Common Shares
2024-12-23$3.85/sh+10,796→ 18,847,343 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Stock Option (Right to Buy)
2024-12-23−10,796→ 16,099,804 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2024-12-23$12.00/sh−10,796→ 18,836,547 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Common Shares
2024-12-18$3.85/sh+412,584→ 19,249,131 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2024-12-18$12.05/sh−412,584→ 18,836,547 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Stock Option (Right to Buy)
2024-12-18−412,584→ 16,110,600 total
Other
Roivant Sciences Ltd.$ROIV
Common Shares
2024-12-03$12.21/sh−3,651,985→ 18,836,547 total
Award
Roivant Sciences Ltd.$ROIV
Common Shares
2024-07-26+17,000,000→ 22,488,532 total
Award
Roivant Sciences Ltd.$ROIV
Common Shares
2024-07-26+1,836,547→ 5,488,532 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Common Shares
2024-03-30+729,081→ 4,018,196 total
Tax Payment
Roivant Sciences Ltd.$ROIV
Common Shares
2024-03-30$10.54/sh−366,211→ 3,651,985 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Capped Value Appreciation Rights
2024-03-30$6.40/sh−1,856,163→ 0 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Common Shares
2023-12-27+71,365→ 3,289,115 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Capped Value Appreciation Rights
2023-12-27$6.40/sh−159,100→ 1,856,163 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Capped Value Appreciation Rights
2023-12-27$11.50/sh−28,411→ 1,306,889 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Capped Value Appreciation Rights
2023-09-27$11.50/sh−28,411→ 1,335,300 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Common Shares
2023-09-27+27,790→ 3,217,750 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Capped Value Appreciation Rights
2023-09-27$6.40/sh−53,033→ 2,015,263 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Common Shares
2023-08-27+22,565→ 3,189,960 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Capped Value Appreciation Rights
2023-08-27$6.40/sh−53,033→ 2,068,296 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Capped Value Appreciation Rights
2023-07-27$6.40/sh−106,067→ 2,121,329 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Common Shares
2023-07-27+43,212→ 3,167,395 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Capped Value Appreciation Rights
2023-05-27$6.40/sh−318,199→ 2,227,396 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Common Shares
2023-05-27+99,458→ 3,124,183 total

Companies

Roivant Sciences Ltd.
Director, President & CIO
$ROIV

Recent Filings

Address

C/O ROIVANT SCIENCES LTD. 7TH FLOOR, 50 BROADWAY

LONDON, SW1H 0DB

View on SEC.gov